Join the session using the link: Zoom Link

Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the patient's rationale for engagement in the clinical trial process.
2| Describe communication styles involved in the informed consent process that aid in clinical trial enrollment.
3| Describe the role of Personal values in the role of decision to participate across clinical trials.

Presenter(s): 
Tashanna Myers, MD
Division Chief, Gynecologic Oncology
Vice Chair, Academic Affairs, Department of OB/GYN
Medical Director of Research, Baystate Health

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Tashanna Myers, MDSpeaker/Moderator/AuthorAdvisory Board, clinical trial oversight - Gilead
Steering committee for GLORISA trial oversight through Abbvie Pharmaceuticals		No

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the others planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.       

Session date: 
03/18/2026 - 2:00pm to 3:00pm EDT
Location: 
Webinar/Zoom
MA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Risk Management
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.